Institute of Immunity and Transplantation, Division of Infection & Immunity, University College London, London, UK.
STAR Protoc. 2022 Apr 29;3(2):101356. doi: 10.1016/j.xpro.2022.101356. eCollection 2022 Jun 17.
With the growing appreciation of tissue-resident immunity, studying tissue-specific immune cells contributing to both homeostasis and disease is imperative. Here, we provide a protocol for the isolation of human intrahepatic leukocytes (IHL) maximizing viability, purity, and yield. Our protocol is scalable by tissue weight, allowing for reproducible and efficient IHL liberation suitable for functional characterization, cell isolation, and profiling by flow (or mass) cytometry. Furthermore, we provide a "guide" to determine an expected IHL yield per gram of tissue processed. For complete details on the use and execution of this protocol, please refer to Stegmann et al. (2016), Pallett et al. (2017), Easom et al. (2018), Swadling et al. (2020), Pallett et al. (2020), and Zakeri et al. (2022).
随着人们对组织驻留免疫的认识不断提高,研究有助于维持组织内稳态和疾病发生的组织特异性免疫细胞至关重要。在这里,我们提供了一种最大限度地提高人肝内白细胞(IHL)活力、纯度和产量的分离方案。我们的方案可按组织重量扩展,能够实现可重复且高效的 IHL 释放,适用于功能特征分析、细胞分离和流式(或质量)细胞术分析。此外,我们还提供了一份“指南”,可确定每克处理组织的预期 IHL 产量。有关使用和执行本方案的完整详细信息,请参考 Stegmann 等人(2016 年)、Pallett 等人(2017 年)、Easom 等人(2018 年)、Swadling 等人(2020 年)、Pallett 等人(2020 年)和 Zakeri 等人(2022 年)。